BioSpace News Archive

The MemorialCare Heart & Vascular Institute at Long Beach Medical Center is the only hospital in Southern California — and one of only four sites in all of California — participating in the Dual Epicardial and Endocardial Procedure clinical trial.

Levity Products Incorporated is pleased to announce the release of a set of newly patented and clinically proven external catheter stabilizers, a new medical device known as The LECS that is expected to revolutionize the catheter stabilization market

Worldwide Rescue & Security, Inc. provides advice to lessen exposure to the virus.

Vaxart, Inc. announced that it has entered into definitive agreements with several institutional investors for the issuance and sale of 4,000,000 shares of its common stock and warrants to purchase up to 2,000,000 shares of its common stock, at a combined purchase price of $2.50 per share and associated warrant, for aggregate gross proceeds of $10.0 million, in a registered direct offering priced at-the-market under Nasdaq rules.

Polaris Inc. announced that it will present at The Raymond James 41st Annual Institutional Investors Conference at the JW Marriott Grande Lakes in Orlando, Florida on Tuesday, March 3, 2020 at 2:15 p.m. Eastern Time.

Immunomedics, Inc., a leading biopharmaceutical company in the area of antibody-drug conjugates, reported financial results for the fourth quarter and full year 2019.

Novan, Inc. (“the Company” or “Novan”) (NASDAQ: NOVN) today announced that it intends to offer and sell a combination of shares of its common stock (or pre-funded warrants to purchase common stock in lieu thereof) and warrants to purchase shares of its common stock in an underwritten public offering.

Tumor outcomes results from two-year follow-up of patients with head and neck cancer treated in Phase 2b clinical trial of avasopasem manganese to be presented at the 2020 Multidisciplinary Head and Neck Cancers Symposium

Strong Q4 2019 revenue growth of 35% driven by a 39% increase in revenue from iCAD’s AI Cancer Detection segment

Tabula Rasa HealthCare, Inc., a healthcare technology company advancing the field of medication safety, announced its financial results for the fourth quarter and full year ended December 31, 2019.